{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:26:05Z","timestamp":1790864765391,"version":"4.1.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002678","name":"Adelaide Research and Innovation, University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s12035-021-02518-3","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T06:46:33Z","timestamp":1629873993000},"page":"5986-6005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?"],"prefix":"10.1007","volume":"58","author":[{"given":"Bianca","family":"Guglietti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srisankavi","family":"Sivasankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-7600","authenticated-orcid":false,"given":"Lyndsey E.","family":"Collins-Praino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"issue":"5","key":"2518_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, Culpepper WJ, Dorsey ER, Elbaz A, Ellenbogen RG (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480","journal-title":"Lancet Neurol"},{"issue":"4","key":"2518_CR2","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim M-O, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 10(4):a033118. https:\/\/doi.org\/10.1101\/cshperspect.a033118","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"2518_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi J-YJ, Collado-Mateo D (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939\u2013953","journal-title":"Lancet Neurol"},{"key":"2518_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P, Thompson T (2020) Current and projected future economic burden of Parkinson\u2019s disease in the U.S. NPJ Parkinsons Dis 6:15. https:\/\/doi.org\/10.1038\/s41531-020-0117-1","journal-title":"NPJ Parkinsons Dis"},{"key":"2518_CR5","doi-asserted-by":"publisher","unstructured":"Cummings J (2017) Disease modification and Neuroprotection in neurodegenerative disorders. Transl Neurodegener 6(1):25. https:\/\/doi.org\/10.1186\/s40035-017-0096-2","DOI":"10.1186\/s40035-017-0096-2"},{"issue":"1","key":"2518_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/alzrt238","volume":"6","author":"HB Nygaard","year":"2014","unstructured":"Nygaard HB, van Dyck CH, Strittmatter SM (2014) Fyn kinase inhibition as a novel therapy for Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 6(1):8. https:\/\/doi.org\/10.1186\/alzrt238","journal-title":"Alzheimer's Res Ther"},{"issue":"11","key":"2518_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1357-2725(98)00089-2","volume":"30","author":"MD Resh","year":"1998","unstructured":"Resh MD (1998) Fyn, a Src family tyrosine kinase. Int J Biochem Cell Biol 30(11):1159\u20131162","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"2518_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.molonc.2009.01.002","volume":"3","author":"TP Green","year":"2009","unstructured":"Green TP, Fennell M, Whittaker R, Curwen J, Jacobs V, Allen J, Logie A, Hargreaves J, Hickinson DM, Wilkinson RW, Elvin P, Boyer B, Carragher N, Pl\u00e9 PA, Bermingham A, Holdgate GA, Ward WH, Hennequin LF, Davies BR, Costello GF (2009) Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Mol Oncol 3(3):248\u2013261. https:\/\/doi.org\/10.1016\/j.molonc.2009.01.002","journal-title":"Mol Oncol"},{"key":"2518_CR9","doi-asserted-by":"publisher","unstructured":"Matrone C, Petrillo F, Nasso R, Ferretti G (2020) Fyn tyrosine kinase as harmonizing factor in neuronal functions and dysfunctions. Int J Mol Sci 21(12):4444. https:\/\/doi.org\/10.3390\/ijms21124444","DOI":"10.3390\/ijms21124444"},{"issue":"4\u20135","key":"2518_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000369995","volume":"37","author":"R Knox","year":"2015","unstructured":"Knox R, Jiang X (2015) Fyn in neurodevelopment and ischemic brain injury. Dev Neurosci 37(4\u20135):311\u2013320. https:\/\/doi.org\/10.1159\/000369995","journal-title":"Dev Neurosci"},{"issue":"12","key":"2518_CR11","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s00018-010-0616-z","volume":"68","author":"EM Kramer-Albers","year":"2011","unstructured":"Kramer-Albers EM, White R (2011) From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci: CMLS 68(12):2003\u20132012. https:\/\/doi.org\/10.1007\/s00018-010-0616-z","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"2518_CR12","doi-asserted-by":"publisher","unstructured":"Panicker N, Saminathan H, Jin H, Neal M, Harischandra DS, Gordon R, Kanthasamy K, Lawana V, Sarkar S, Luo J, Anantharam V, Kanthasamy AG, Kanthasamy A (2015) Fyn kinase regulates microglial neuroinflammatory responses in cell culture and animal models of Parkinson\u2019s disease. J Neurosci 35(27):10058. https:\/\/doi.org\/10.1523\/JNEUROSCI.0302-15.2015","DOI":"10.1523\/JNEUROSCI.0302-15.2015"},{"issue":"2","key":"2518_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1023\/a:1018418224660","volume":"5","author":"T Sherratt","year":"1997","unstructured":"Sherratt T, Morelli C, Boyle JM, Harrison CJ (1997) Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21. Chromosome Res 5(2):118\u2013124. https:\/\/doi.org\/10.1023\/a:1018418224660","journal-title":"Chromosome Res"},{"issue":"1","key":"2518_CR14","first-page":"66","volume":"1","author":"MP Cooke","year":"1989","unstructured":"Cooke MP, Perlmutter RM (1989) Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol 1(1):66\u201374","journal-title":"New Biol"},{"issue":"4","key":"2518_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0006-291x(02)02510-x","volume":"298","author":"JF Goldsmith","year":"2002","unstructured":"Goldsmith JF, Hall CG, Atkinson TP (2002) Identification of an alternatively spliced isoform of the fyn tyrosine kinase. Biochem Biophys Res Commun 298(4):501\u2013504. https:\/\/doi.org\/10.1016\/s0006-291x(02)02510-x","journal-title":"Biochem Biophys Res Commun"},{"issue":"48","key":"2518_CR16","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1038\/sj.onc.1208081","volume":"23","author":"TJ Boggon","year":"2004","unstructured":"Boggon TJ, Eck MJ (2004) Structure and regulation of Src family kinases. Oncogene 23(48):7918\u20137927. https:\/\/doi.org\/10.1038\/sj.onc.1208081","journal-title":"Oncogene"},{"issue":"3","key":"2518_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0304-419x(93)90012-2","volume":"1155","author":"MD Resh","year":"1993","unstructured":"Resh MD (1993) Interaction of tyrosine kinase oncoproteins with cellular membranes. Biochim Biophys Acta 1155(3):307\u2013322. https:\/\/doi.org\/10.1016\/0304-419x(93)90012-2","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2518_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jcp.22335","volume":"226","author":"MG Yeo","year":"2011","unstructured":"Yeo MG, Oh HJ, Cho HS, Chun JS, Marcantonio EE, Song WK (2011) Phosphorylation of Ser 21 in Fyn regulates its kinase activity, focal adhesion targeting, and is required for cell migration. J Cell Physiol 226(1):236\u2013247. https:\/\/doi.org\/10.1002\/jcp.22335","journal-title":"J Cell Physiol"},{"key":"2518_CR19","doi-asserted-by":"publisher","unstructured":"Barua D, Hlavacek WS, Lipniacki T (2012) A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn. J Immunol 189(2):646\u2013658. https:\/\/doi.org\/10.4049\/jimmunol.1102003","DOI":"10.4049\/jimmunol.1102003"},{"issue":"10","key":"2518_CR20","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1073\/pnas.91.10.4268","volume":"91","author":"CM Pleiman","year":"1994","unstructured":"Pleiman CM, Abrams C, Gauen LT, Bedzyk W, Jongstra J, Shaw AS, Cambier JC (1994) Distinct p53\/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha. Proc Natl Acad Sci USA 91(10):4268\u20134272. https:\/\/doi.org\/10.1073\/pnas.91.10.4268","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6617","key":"2518_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/385595a0","volume":"385","author":"W Xu","year":"1997","unstructured":"Xu W, Harrison SC, Eck MJ (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385(6617):595\u2013602. https:\/\/doi.org\/10.1038\/385595a0","journal-title":"Nature"},{"issue":"2","key":"2518_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/bbrc.1997.7743","volume":"241","author":"K Hansen","year":"1997","unstructured":"Hansen K, Alonso G, Courtneidge SA, R\u00f6nnstrand L, Heldin CH (1997) PDGF-induced phosphorylation of Tyr28 in the N-terminus of Fyn affects Fyn activation. Biochem Biophys Res Commun 241(2):355\u2013362. https:\/\/doi.org\/10.1006\/bbrc.1997.7743","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2518_CR23","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s00018-010-0616-z","volume":"68","author":"E-m Kr\u00e4mer-albers","year":"2011","unstructured":"Kr\u00e4mer-albers E-m, White R (2011) From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci 68(12):2003\u20132012. https:\/\/doi.org\/10.1007\/s00018-010-0616-z","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2518_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1128\/jvi.65.1.170-179.1991","volume":"65","author":"SH Cheng","year":"1991","unstructured":"Cheng SH, Espino PC, Marshall J, Harvey R, Merrill J, Smith AE (1991) Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen. J Virol 65(1):170\u2013179. https:\/\/doi.org\/10.1128\/jvi.65.1.170-179.1991","journal-title":"J Virol"},{"issue":"10","key":"2518_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/s0960-9822(99)80238-3","volume":"9","author":"S Ponniah","year":"1999","unstructured":"Ponniah S, Wang DZ, Lim KL, Pallen CJ (1999) Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr Biol 9(10):535\u2013538. https:\/\/doi.org\/10.1016\/s0960-9822(99)80238-3","journal-title":"Curr Biol"},{"issue":"2","key":"2518_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3233\/jad-2011-110353","volume":"27","author":"K Yang","year":"2011","unstructured":"Yang K, Belrose J, Trepanier CH, Lei G, Jackson MF, MacDonald JF (2011) Fyn, a potential target for Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 27(2):243\u2013252. https:\/\/doi.org\/10.3233\/jad-2011-110353","journal-title":"J Alzheimer's Dis: JAD"},{"issue":"27","key":"2518_CR27","doi-asserted-by":"publisher","first-page":"24274","DOI":"10.1074\/jbc.M111683200","volume":"277","author":"TH Nguyen","year":"2002","unstructured":"Nguyen TH, Liu J, Lombroso PJ (2002) Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J Biol Chem 277(27):24274\u201324279. https:\/\/doi.org\/10.1074\/jbc.M111683200","journal-title":"J Biol Chem"},{"issue":"15","key":"2518_CR28","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1074\/jbc.273.15.8691","volume":"273","author":"V Bhandari","year":"1998","unstructured":"Bhandari V, Lim KL, Pallen CJ (1998) Physical and functional interactions between receptor-like protein-tyrosine phosphatase alpha and p59fyn. J Biol Chem 273(15):8691\u20138698. https:\/\/doi.org\/10.1074\/jbc.273.15.8691","journal-title":"J Biol Chem"},{"issue":"2","key":"2518_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1006\/bbrc.1995.2662","volume":"216","author":"T Suzuki","year":"1995","unstructured":"Suzuki T, Okumura-Noji K (1995) NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem Biophys Res Commun 216(2):582\u2013588. https:\/\/doi.org\/10.1006\/bbrc.1995.2662","journal-title":"Biochem Biophys Res Commun"},{"issue":"28","key":"2518_CR30","doi-asserted-by":"publisher","first-page":"20075","DOI":"10.1074\/jbc.M700624200","volume":"282","author":"HY Wu","year":"2007","unstructured":"Wu HY, Hsu FC, Gleichman AJ, Baconguis I, Coulter DA, Lynch DR (2007) Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. J Biol Chem 282(28):20075\u201320087. https:\/\/doi.org\/10.1074\/jbc.M700624200","journal-title":"J Biol Chem"},{"key":"2518_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-384913-7.00001-0","volume-title":"Neuroinflammation","author":"A-H Maghzi","year":"2011","unstructured":"Maghzi A-H, Borazanci A, McGee J, Steven Alexander J, Gonzalez-Toledo E, Minagar A (2011) 1 - Multiple sclerosis: pathophysiology, clinical features, diagnosis, and management. In: Minagar A (ed) Neuroinflammation. Elsevier, London, pp 1\u201323. https:\/\/doi.org\/10.1016\/B978-0-12-384913-7.00001-0"},{"issue":"4","key":"2518_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/s1474-4422(14)70305-9","volume":"14","author":"B Hemmer","year":"2015","unstructured":"Hemmer B, Kerschensteiner M, Korn T (2015) Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol 14(4):406\u2013419. https:\/\/doi.org\/10.1016\/s1474-4422(14)70305-9","journal-title":"Lancet Neurol"},{"issue":"1","key":"2518_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1682\/jrrd.2004.08.0111","volume":"43","author":"C Cudrici","year":"2006","unstructured":"Cudrici C, Niculescu T, Niculescu F, Shin ML, Rus H (2006) Oligodendrocyte cell death in pathogenesis of multiple sclerosis: protection of oligodendrocytes from apoptosis by complement. J Rehabil Res Dev 43(1):123. https:\/\/doi.org\/10.1682\/jrrd.2004.08.0111","journal-title":"J Rehabil Res Dev"},{"issue":"4","key":"2518_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/1097-4547(20010215)63:4<303::aid-jnr1024>3.0.co;2-a","volume":"63","author":"BR Sperber","year":"2001","unstructured":"Sperber BR, McMorris FA (2001) Fyn tyrosine kinase regulates oligodendroglial cell development but is not required for morphological differentiation of oligodendrocytes. J Neurosci Res 63(4):303\u2013312. https:\/\/doi.org\/10.1002\/1097-4547(20010215)63:4%3c303::aid-jnr1024%3e3.0.co;2-a","journal-title":"J Neurosci Res"},{"issue":"1","key":"2518_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40478-016-0317-4","volume":"4","author":"DH Lau","year":"2016","unstructured":"Lau DH, Hogseth M, Phillips EC, O\u2019Neill MJ, Pooler AM, Noble W, Hanger DP (2016) Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer\u2019s disease. Acta Neuropathol Commun 4(1):49. https:\/\/doi.org\/10.1186\/s40478-016-0317-4","journal-title":"Acta Neuropathol Commun"},{"issue":"48","key":"2518_CR36","doi-asserted-by":"publisher","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","volume":"23","author":"EH Palacios","year":"2004","unstructured":"Palacios EH, Weiss A (2004) Function of the Src-family kinases, Lck and Fyn T-cell development and activation. Oncogene 23(48):7990\u20138000. https:\/\/doi.org\/10.1038\/sj.onc.1208074","journal-title":"Oncogene"},{"issue":"6463","key":"2518_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/367572a0","volume":"367","author":"H Umemori","year":"1994","unstructured":"Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T (1994) Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 367(6463):572\u2013576. https:\/\/doi.org\/10.1038\/367572a0","journal-title":"Nature"},{"issue":"11","key":"2518_CR38","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/hmg\/ddp120","volume":"18","author":"SE Baranzini","year":"2009","unstructured":"Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, Wu W, Uitdehaag BMJ, Kappos L, Polman CH, Matthews PM, Hauser SL, Gibson RA, Oksenberg JR, Barnes MR (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18(11):2078\u20132090. https:\/\/doi.org\/10.1093\/hmg\/ddp120","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2518_CR39","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1083\/jcb.145.6.1209","volume":"145","author":"DJ Osterhout","year":"1999","unstructured":"Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV (1999) Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol 145(6):1209\u20131218","journal-title":"J Cell Biol"},{"key":"2518_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/B978-0-12-384913-7.00009-5","volume-title":"Neuroinflammation","author":"M Stangel","year":"2011","unstructured":"Stangel M, Pul R, Skripuletz T, Trebst C, Voss E, Gudi V (2011) 9 - Remyelination in multiple sclerosis. In: Minagar A (ed) Neuroinflammation. Elsevier, London, pp 193\u2013223. https:\/\/doi.org\/10.1016\/B978-0-12-384913-7.00009-5"},{"issue":"8","key":"2518_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/cells8080825","volume":"8","author":"J Gruchot","year":"2019","unstructured":"Gruchot J, Weyers V, G\u00f6ttle P, F\u00f6rster M, Hartung H-P, K\u00fcry P, Kremer D (2019) The molecular basis for remyelination failure in multiple sclerosis. Cells 8(8):825. https:\/\/doi.org\/10.3390\/cells8080825","journal-title":"Cells"},{"issue":"6","key":"2518_CR42","first-page":"1429","volume":"8","author":"DJ Bare","year":"1993","unstructured":"Bare DJ, Lauder JM, Wilkie MB, Maness PF (1993) p59fyn in rat brain is localized in developing axonal tracts and subpopulations of adult neurons and glia. Oncogene 8(6):1429\u20131436","journal-title":"Oncogene"},{"issue":"3","key":"2518_CR43","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/(SICI)1097-4547(20000201)59:3<430::AID-JNR18>3.0.CO;2-7","volume":"59","author":"M Scarlato","year":"2000","unstructured":"Scarlato M, Beesley J, Pleasure D (2000) Analysis of oligodendroglial differentiation using cDNA arrays. J Neurosci Res 59(3):430\u2013435. https:\/\/doi.org\/10.1002\/(SICI)1097-4547(20000201)59:3%3c430::AID-JNR18%3e3.0.CO;2-7","journal-title":"J Neurosci Res"},{"issue":"33","key":"2518_CR44","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1523\/JNEUROSCI.1482-08.2008","volume":"28","author":"Y Miyamoto","year":"2008","unstructured":"Miyamoto Y, Yamauchi J, Tanoue A (2008) Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn. J Neurosci 28(33):8326\u20138337. https:\/\/doi.org\/10.1523\/JNEUROSCI.1482-08.2008","journal-title":"J Neurosci"},{"key":"2518_CR45","doi-asserted-by":"publisher","unstructured":"White R, Kr\u00e4mer-Albers E-M (2014) Axon-glia interaction and membrane traffic in myelin formation. Front Cell Neurosci 7(284). https:\/\/doi.org\/10.3389\/fncel.2013.00284","DOI":"10.3389\/fncel.2013.00284"},{"key":"2518_CR46","doi-asserted-by":"publisher","unstructured":"Wolf R, Wilkes J, Chao M, Resh M (2001) Tyrosine phosphorylation of p190 RHOGAP by Fyn regulates oligodendrocyte differentiation. J Neurobiol 49(1):62\u201378. https:\/\/doi.org\/10.1002\/neu.1066","DOI":"10.1002\/neu.1066"},{"issue":"32","key":"2518_CR47","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1523\/jneurosci.5319-03.2004","volume":"24","author":"X Liang","year":"2004","unstructured":"Liang X, Draghi NA, Resh MD (2004) Signaling from integrins to Fyn to rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 24(32):7140\u20137149. https:\/\/doi.org\/10.1523\/jneurosci.5319-03.2004","journal-title":"J Neurosci"},{"key":"2518_CR48","doi-asserted-by":"publisher","unstructured":"Rajasekharan S, Bin J, Antel J, Kennedy T (2010) A central role for RhoA during oligodendroglial maturation in the switch from Netrin-1-mediated chemorepulsion to process elaboration. J Neurochem 113(6):1589\u20131597. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06717.x","DOI":"10.1111\/j.1471-4159.2010.06717.x"},{"issue":"3","key":"2518_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0092-8674(92)90164-8","volume":"70","author":"AJ Ridley","year":"1992","unstructured":"Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70(3):401\u2013410. https:\/\/doi.org\/10.1016\/0092-8674(92)90164-8","journal-title":"Cell"},{"issue":"1","key":"2518_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/glia.1098","volume":"36","author":"M Gorath","year":"2001","unstructured":"Gorath M, Stahnke T, Mronga T, Goldbaum O, Richter-Landsberg C (2001) Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia 36(1):89\u2013101. https:\/\/doi.org\/10.1002\/glia.1098","journal-title":"Glia"},{"issue":"1","key":"2518_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12031-007-9017-7","volume":"35","author":"C Richter-Landsberg","year":"2008","unstructured":"Richter-Landsberg C (2008) The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease. J Mol Neurosci 35(1):55\u201363. https:\/\/doi.org\/10.1007\/s12031-007-9017-7","journal-title":"J Mol Neurosci"},{"issue":"41","key":"2518_CR52","doi-asserted-by":"publisher","first-page":"29042","DOI":"10.1074\/jbc.274.41.29042","volume":"274","author":"EM Kramer","year":"1999","unstructured":"Kramer EM, Klein C, Koch T, Boytinck M, Trotter J (1999) Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem 274(41):29042\u201329049. https:\/\/doi.org\/10.1074\/jbc.274.41.29042","journal-title":"J Biol Chem"},{"issue":"3","key":"2518_CR53","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1523\/jneurosci.22-03-00698.2002","volume":"22","author":"C Klein","year":"2002","unstructured":"Klein C, Kr\u00e4mer E-M, Cardine A-M, Schraven B, Brandt R, Trotter J (2002) Process outgrowth of oligodendrocytes is promoted by interaction of Fyn kinase with the cytoskeletal protein tau. J Neurosci 22(3):698\u2013707. https:\/\/doi.org\/10.1523\/jneurosci.22-03-00698.2002","journal-title":"J Neurosci"},{"issue":"7","key":"2518_CR54","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.4049\/jimmunol.176.7.4201","volume":"176","author":"NB Mart\u00edn-C\u00f3freces","year":"2006","unstructured":"Mart\u00edn-C\u00f3freces NB, Sancho D, Fern\u00e1ndez E, Vicente-Manzanares M, Gord\u00f3n-Alonso M, Montoya MC, Michel F, Acuto O, Alarc\u00f3n B, S\u00e1nchez-Madrid F (2006) Role of Fyn in the rearrangement of tubulin cytoskeleton induced through TCR. J Immunol 176(7):4201\u20134207. https:\/\/doi.org\/10.4049\/jimmunol.176.7.4201","journal-title":"J Immunol"},{"key":"2518_CR55","doi-asserted-by":"publisher","unstructured":"Laursen LS, Chan CW, ffrench-Constant C (2009) An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J Neurosci 29(29):9174\u20139185. https:\/\/doi.org\/10.1523\/JNEUROSCI.5942-08.2009","DOI":"10.1523\/JNEUROSCI.5942-08.2009"},{"issue":"4","key":"2518_CR56","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1083\/jcb.200706164","volume":"181","author":"R White","year":"2008","unstructured":"White R, Gonsior C, Kramer-Albers EM, Stohr N, Huttelmaier S, Trotter J (2008) Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA granules. J Cell Biol 181(4):579\u2013586. https:\/\/doi.org\/10.1083\/jcb.200706164","journal-title":"J Cell Biol"},{"issue":"8","key":"2518_CR57","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/emboj\/cdg171","volume":"22","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Lu Z, Ku L, Chen Y, Wang H, Feng Y (2003) Tyrosine phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism. EMBO J 22(8):1801\u20131810. https:\/\/doi.org\/10.1093\/emboj\/cdg171","journal-title":"EMBO J"},{"key":"2518_CR58","doi-asserted-by":"publisher","unstructured":"Wake H, Lee PR, Fields RD (2011) Control of local protein synthesis and initial events in myelination by action potentials. Science 333(6049):1647\u20131651. https:\/\/doi.org\/10.1126\/science.1206998","DOI":"10.1126\/science.1206998"},{"key":"2518_CR59","doi-asserted-by":"publisher","unstructured":"Peckham H, Giuffrida L, Wood R, Gonsalvez D, Ferner A, Kilpatrick TJ, Murray SS, Xiao J (2016) Fyn is an intermediate kinase that BDNF utilizes to promote oligodendrocyte myelination. Glia 64(2):255\u2013269. https:\/\/doi.org\/10.1002\/glia.22927","DOI":"10.1002\/glia.22927"},{"issue":"13","key":"2518_CR60","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1128\/MCB.01178-09","volume":"30","author":"AK Pullikuth","year":"2010","unstructured":"Pullikuth AK, Catling AD (2010) Extracellular signal-regulated kinase promotes Rho-dependent focal adhesion formation by suppressing p190A RhoGAP. Mol Cell Biol 30(13):3233\u20133248. https:\/\/doi.org\/10.1128\/MCB.01178-09","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2518_CR61","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00401-011-0890-3","volume":"123","author":"D-H Lee","year":"2012","unstructured":"Lee D-H, Geyer E, Flach A-C, Jung K, Gold R, Fl\u00fcgel A, Linker RA, L\u00fchder F (2012) Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination. Acta Neuropathol 123(2):247\u2013258. https:\/\/doi.org\/10.1007\/s00401-011-0890-3","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2518_CR62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2990.2007.00892.x","volume":"34","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Schittenhelm J, Meyermann R, Schluesener HJ (2008) Lesional accumulation of RhoA+cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis. Neuropathol Appl Neurobiol 34(2):231\u2013240. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00892.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"2518_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0168-0102(00)00100-0","volume":"37","author":"C Seiwa","year":"2000","unstructured":"Seiwa C, Sugiyama I, Yagi T, Iguchi T, Asou H (2000) Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system. Neurosci Res 37(1):21\u201331. https:\/\/doi.org\/10.1016\/s0168-0102(00)00100-0","journal-title":"Neurosci Res"},{"issue":"8","key":"2518_CR64","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s11064-016-1920-2","volume":"41","author":"L Yang","year":"2016","unstructured":"Yang L, Tan D, Piao H (2016) Myelin basic protein citrullination in multiple sclerosis: a potential therapeutic target for the pathology. Neurochem Res 41(8):1845\u20131856. https:\/\/doi.org\/10.1007\/s11064-016-1920-2","journal-title":"Neurochem Res"},{"issue":"5","key":"2518_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s1074-7613(00)80498-7","volume":"5","author":"T Groves","year":"1996","unstructured":"Groves T, Smiley P, Cooke MP, Forbush K, Perlmutter RM, Guidos CJ (1996) Fyn can partially substitute for Lck in T lymphocyte development. Immunity 5(5):417\u2013428. https:\/\/doi.org\/10.1016\/s1074-7613(00)80498-7","journal-title":"Immunity"},{"issue":"5","key":"2518_CR66","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/s1074-7613(00)80499-9","volume":"5","author":"NS van Oers","year":"1996","unstructured":"van Oers NS, Lowin-Kropf B, Finlay D, Connolly K, Weiss A (1996) alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 5(5):429\u2013436. https:\/\/doi.org\/10.1016\/s1074-7613(00)80499-9","journal-title":"Immunity"},{"issue":"5","key":"2518_CR67","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10(5):514\u2013523. https:\/\/doi.org\/10.1038\/ni.1716","journal-title":"Nat Immunol"},{"issue":"4","key":"2518_CR68","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","volume":"24","author":"AC Murphy","year":"2010","unstructured":"Murphy AC, Lalor SJ, Lynch MA, Mills KH (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24(4):641\u2013651. https:\/\/doi.org\/10.1016\/j.bbi.2010.01.014","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2518_CR69","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","volume":"11","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Pacheco R (2014) T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 11(1):201. https:\/\/doi.org\/10.1186\/s12974-014-0201-8","journal-title":"J Neuroinflammation"},{"issue":"11","key":"2518_CR70","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.4049\/jimmunol.1102241","volume":"188","author":"A Ueda","year":"2012","unstructured":"Ueda A, Zhou L, Stein PL (2012) Fyn promotes Th17 differentiation by regulating the kinetics of ROR\u03b3t and Foxp3 expression. J Immunol 188(11):5247\u20135256. https:\/\/doi.org\/10.4049\/jimmunol.1102241","journal-title":"J Immunol"},{"key":"2518_CR71","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s Association (2020) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 16(3):391\u2013460. https:\/\/doi.org\/10.1002\/alz.12068","DOI":"10.1002\/alz.12068"},{"issue":"3","key":"2518_CR72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/syn.20599","volume":"63","author":"L Cheng","year":"2009","unstructured":"Cheng L, Yin WJ, Zhang JF, Qi JS (2009) Amyloid beta-protein fragments 25\u201335 and 31\u201335 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse 63(3):206\u2013214. https:\/\/doi.org\/10.1002\/syn.20599","journal-title":"Synapse"},{"issue":"1","key":"2518_CR73","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192(1):106\u2013113. https:\/\/doi.org\/10.1016\/j.bbr.2008.02.016","journal-title":"Behav Brain Res"},{"issue":"4","key":"2518_CR74","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00001756-199304000-00024","volume":"4","author":"SK Shirazi","year":"1993","unstructured":"Shirazi SK, Wood JG (1993) The protein tyrosine kinase, fyn, Alzheimer\u2019s disease pathology. NeuroReport 4(4):435\u2013437. https:\/\/doi.org\/10.1097\/00001756-199304000-00024","journal-title":"NeuroReport"},{"issue":"3","key":"2518_CR75","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/jnc.13429","volume":"136","author":"C Lee","year":"2016","unstructured":"Lee C, Low CY, Francis PT, Attems J, Wong PT, Lai MK, Tan MG (2016) An isoform-specific role of FynT tyrosine kinase in Alzheimer\u2019s disease. J Neurochem 136(3):637\u2013650. https:\/\/doi.org\/10.1111\/jnc.13429","journal-title":"J Neurochem"},{"key":"2518_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12917","author":"CYB Low","year":"2021","unstructured":"Low CYB, Lee JH, Lim FTW, Lee C, Ballard C, Francis PT, Lai MKP, Tan MGK (2021) Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer\u2019s disease and Lewy body dementias. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12917","journal-title":"Brain Pathol"},{"issue":"1","key":"2518_CR77","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O'Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34(1):185\u2013204. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113613","journal-title":"Annu Rev Neurosci"},{"issue":"18","key":"2518_CR78","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1523\/jneurosci.0203-11.2011","volume":"31","author":"S Li","year":"2011","unstructured":"Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ (2011) Soluble A oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci 31(18):6627\u20136638. https:\/\/doi.org\/10.1523\/jneurosci.0203-11.2011","journal-title":"J Neurosci"},{"key":"2518_CR79","doi-asserted-by":"publisher","unstructured":"Iannuzzi F, Sirabella R, Canu N, Maier TJ, Annunziato L, Matrone C (2020) Fyn tyrosine kinase elicits amyloid precursor protein Tyr682 phosphorylation in neurons from Alzheimer's disease patients. Cells 9(8):1807. https:\/\/doi.org\/10.3390\/cells9081807","DOI":"10.3390\/cells9081807"},{"key":"2518_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnmol.2017.00059","volume":"10","author":"ET Poulsen","year":"2017","unstructured":"Poulsen ET, Iannuzzi F, Rasmussen HF, Maier TJ, Enghild JJ, Jorgensen AL, Matrone C (2017) An aberrant phosphorylation of amyloid precursor protein tyrosine regulates its trafficking and the binding to the clathrin endocytic complex in neural stem cells of Alzheimer\u2019s disease patients. Front Mol Neurosci 10:59. https:\/\/doi.org\/10.3389\/fnmol.2017.00059","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"2518_CR81","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.mp.4001508","volume":"9","author":"J Gotz","year":"2004","unstructured":"Gotz J, Streffer JR, David D, Schild A, Hoerndli F, Pennanen L, Kurosinski P, Chen F (2004) Transgenic animal models of Alzheimer\u2019s disease and related disorders: histopathology, behavior and therapy. Mol Psychiatry 9(7):664\u2013683. https:\/\/doi.org\/10.1038\/sj.mp.4001508","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2518_CR82","doi-asserted-by":"publisher","first-page":"12473","DOI":"10.1038\/s41598-019-48790-1","volume":"9","author":"J Hervy","year":"2019","unstructured":"Hervy J, Bicout DJ (2019) Dynamical decoration of stabilized-microtubules by Tau-proteins. Sci Rep 9(1):12473. https:\/\/doi.org\/10.1038\/s41598-019-48790-1","journal-title":"Sci Rep"},{"issue":"2","key":"2518_CR83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, Gotz J (2011) Amyloid-beta and tau\u2013a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12(2):65\u201372. https:\/\/doi.org\/10.1038\/nrn2967","journal-title":"Nat Rev Neurosci"},{"key":"2518_CR84","doi-asserted-by":"publisher","first-page":"8501693","DOI":"10.1155\/2016\/8501693","volume":"2016","author":"J Folch","year":"2016","unstructured":"Folch J, Petrov D, Ettcheto M, Abad S, Sanchez-Lopez E, Garcia ML, Olloquequi J, Beas-Zarate C, Auladell C, Camins A (2016) Current research therapeutic strategies for Alzheimer\u2019s disease treatment. Neural Plast 2016:8501693. https:\/\/doi.org\/10.1155\/2016\/8501693","journal-title":"Neural Plast"},{"issue":"21","key":"2518_CR85","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.15252\/embj.201797724","volume":"36","author":"C Li","year":"2017","unstructured":"Li C, G\u00f6tz J (2017) Somatodendritic accumulation of Tau in Alzheimer\u2019s disease is promoted by Fyn-mediated local protein translation. EMBO J 36(21):3120\u20133138. https:\/\/doi.org\/10.15252\/embj.201797724","journal-title":"EMBO J"},{"issue":"47","key":"2518_CR86","doi-asserted-by":"publisher","first-page":"16857","DOI":"10.1523\/jneurosci.1858-12.2012","volume":"32","author":"M Larson","year":"2012","unstructured":"Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesne SE (2012) The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer\u2019s disease. J Neurosci 32(47):16857\u201316871a. https:\/\/doi.org\/10.1523\/jneurosci.1858-12.2012","journal-title":"J Neurosci"},{"issue":"2","key":"2518_CR87","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.bbrc.2016.08.037","volume":"478","author":"W Liu","year":"2016","unstructured":"Liu W, Zhao J, Lu G (2016) miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer\u2019s disease. Biochem Biophys Res Commun 478(2):852\u2013857. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.037","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2518_CR88","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68(6):1067\u20131081. https:\/\/doi.org\/10.1016\/j.neuron.2010.11.030","journal-title":"Neuron"},{"key":"2518_CR89","doi-asserted-by":"publisher","unstructured":"Yang T, Tran KC, Zeng AY, Massa SM, Longo FM (2020) Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies. Sci Rep 10(1):20322. https:\/\/doi.org\/10.1038\/s41598-020-77210-y","DOI":"10.1038\/s41598-020-77210-y"},{"issue":"7","key":"2518_CR90","doi-asserted-by":"publisher","first-page":"e0224952","DOI":"10.1371\/journal.pone.0224952","volume":"15","author":"H Yadikar","year":"2020","unstructured":"Yadikar H, Torres I, Aiello G, Kurup M, Yang Z, Lin F, Kobeissy F, Yost R, Wang KK (2020) Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization. PLoS ONE 15(7):e0224952. https:\/\/doi.org\/10.1371\/journal.pone.0224952","journal-title":"PLoS ONE"},{"key":"2518_CR91","doi-asserted-by":"publisher","unstructured":"Tang SJ, Fesharaki-Zadeh A, Takahashi H, Nies SH, Smith LM, Luo A, Chyung A, Chiasseu M, Strittmatter SM (2020) Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy. Acta Neuropathol Commun 8(1):96. https:\/\/doi.org\/10.1186\/s40478-020-00976-9","DOI":"10.1186\/s40478-020-00976-9"},{"key":"2518_CR92","doi-asserted-by":"publisher","first-page":"104668","DOI":"10.1016\/j.nbd.2019.104668","volume":"134","author":"T Rush","year":"2020","unstructured":"Rush T, Roth JR, Thompson SJ, Aldaher AR, Cochran JN, Roberson ED (2020) A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-beta toxicity. Neurobiol Dis 134:104668. https:\/\/doi.org\/10.1016\/j.nbd.2019.104668","journal-title":"Neurobiol Dis"},{"key":"2518_CR93","doi-asserted-by":"publisher","unstructured":"Luscher C, Malenka RC (2012) NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD). Cold Spring Harb Perspect Biol 4(6):a005710. https:\/\/doi.org\/10.1101\/cshperspect.a005710","DOI":"10.1101\/cshperspect.a005710"},{"issue":"1","key":"2518_CR94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1742-4658.2011.08391.x","volume":"279","author":"CH Trepanier","year":"2012","unstructured":"Trepanier CH, Jackson MF, Macdonald JF (2012) Regulation of NMDA receptors by the tyrosine kinase Fyn. FEBS J 279(1):12\u201319. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08391.x","journal-title":"FEBS J"},{"issue":"1","key":"2518_CR95","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1074\/jbc.M008085200","volume":"276","author":"T Nakazawa","year":"2001","unstructured":"Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K, Mishina M, Manabe T, Yamamoto T (2001) Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem 276(1):693\u2013699. https:\/\/doi.org\/10.1074\/jbc.M008085200","journal-title":"J Biol Chem"},{"issue":"8","key":"2518_CR96","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/cns.12095","volume":"19","author":"Z Esposito","year":"2013","unstructured":"Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A (2013) Amyloid \u03b2, glutamate, excitotoxicity in Alzheimer\u2019s disease: are we on the right track? CNS Neurosci Ther 19(8):549\u2013555. https:\/\/doi.org\/10.1111\/cns.12095","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"2518_CR97","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM (2012) Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15(9):1227\u20131235. https:\/\/doi.org\/10.1038\/nn.3178","journal-title":"Nat Neurosci"},{"key":"2518_CR98","doi-asserted-by":"publisher","unstructured":"Miyamoto T, Stein L, Thomas R, Djukic B, Taneja P, Knox J, Vossel K, Mucke L (2017) Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture. Mol Neurodegener 12(1):42. https:\/\/doi.org\/10.1186\/s13024-017-0176-x","DOI":"10.1186\/s13024-017-0176-x"},{"issue":"1","key":"2518_CR99","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4161\/pri.22212","volume":"7","author":"JW Um","year":"2013","unstructured":"Um JW, Strittmatter SM (2013) Amyloid-beta induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion 7(1):37\u201341. https:\/\/doi.org\/10.4161\/pri.22212","journal-title":"Prion"},{"issue":"1","key":"2518_CR100","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1471-4159.2009.06123.x","volume":"110","author":"B Pantera","year":"2009","unstructured":"Pantera B, Bini C, Cirri P, Paoli P, Camici G, Manao G, Caselli A (2009) PrPc activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway. J Neurochem 110(1):194\u2013207. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06123.x","journal-title":"J Neurochem"},{"key":"2518_CR101","doi-asserted-by":"publisher","unstructured":"Stuermer CA, Langhorst MF, Wiechers MF, Legler DF, Von Hanwehr SH, Guse AH, Plattner H (2004) PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction. FASEB J 18(14):1731\u20131733. https:\/\/doi.org\/10.1096\/fj.04-2150fje","DOI":"10.1096\/fj.04-2150fje"},{"issue":"8","key":"2518_CR102","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2004.10.004","volume":"26","author":"K Schwarze-Eicker","year":"2005","unstructured":"Schwarze-Eicker K, Keyvani K, Gortz N, Westaway D, Sachser N, Paulus W (2005) Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiol Aging 26(8):1177\u20131182. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.10.004","journal-title":"Neurobiol Aging"},{"issue":"7233","key":"2518_CR103","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Laur\u00e9n","year":"2009","unstructured":"Laur\u00e9n J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-\u03b2 oligomers. Nature 457(7233):1128\u20131132. https:\/\/doi.org\/10.1038\/nature07761","journal-title":"Nature"},{"issue":"5","key":"2518_CR104","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","volume":"66","author":"M Renner","year":"2010","unstructured":"Renner M, Lacor PN, Velasco PT, Xu J, Contractor A, Klein WL, Triller A (2010) Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 66(5):739\u2013754. https:\/\/doi.org\/10.1016\/j.neuron.2010.04.029","journal-title":"Neuron"},{"issue":"4","key":"2518_CR105","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J Neurosci 27(4):796\u2013807. https:\/\/doi.org\/10.1523\/JNEUROSCI.3501-06.2007","journal-title":"J Neurosci"},{"issue":"3","key":"2518_CR106","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M, Asfaw A, Hall TC, Ding L, Desousa A, Frosch MP, Collinge J, Harris DA, Perkinton MS, Spires-Jones TL, Young-Pearse TL, Billinton A, Walsh DM (2020) PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol 139(3):503\u2013526. https:\/\/doi.org\/10.1007\/s00401-019-02114-9","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2518_CR107","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell 142(3):387\u2013397. https:\/\/doi.org\/10.1016\/j.cell.2010.06.036","journal-title":"Cell"},{"issue":"42","key":"2518_CR108","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1523\/jneurosci.2980-05.2005","volume":"25","author":"J Chin","year":"2005","unstructured":"Chin J, Palop JJ, Puolivali J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E, Mucke L (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 25(42):9694\u20139703. https:\/\/doi.org\/10.1523\/jneurosci.2980-05.2005","journal-title":"J Neurosci"},{"issue":"1","key":"2518_CR109","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/hipo.20592","volume":"20","author":"F Pena","year":"2010","unstructured":"Pena F, Ordaz B, Balleza-Tapia H, Bernal-Pedraza R, Marquez-Ramos A, Carmona-Aparicio L, Giordano M (2010) Beta-amyloid protein (25\u201335) disrupts hippocampal network activity: role of Fyn-kinase. Hippocampus 20(1):78\u201396. https:\/\/doi.org\/10.1002\/hipo.20592","journal-title":"Hippocampus"},{"issue":"19","key":"2518_CR110","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1523\/jneurosci.0277-04.2004","volume":"24","author":"J Chin","year":"2004","unstructured":"Chin J, Palop JJ, Yu GQ, Kojima N, Masliah E, Mucke L (2004) Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J Neurosci 24(19):4692\u20134697. https:\/\/doi.org\/10.1523\/jneurosci.0277-04.2004","journal-title":"J Neurosci"},{"issue":"8","key":"2518_CR111","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/emmm.201302771","volume":"5","author":"I Lonskaya","year":"2013","unstructured":"Lonskaya I, Hebron ML, Desforges NM, Franjie A, Moussa CE (2013) Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance. EMBO Mol Med 5(8):1247\u20131262. https:\/\/doi.org\/10.1002\/emmm.201302771","journal-title":"EMBO Mol Med"},{"issue":"4","key":"2518_CR112","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","volume":"83","author":"HB Nygaard","year":"2018","unstructured":"Nygaard HB (2018) Targeting Fyn kinase in Alzheimer\u2019s disease. Biol Psychiatry 83(4):369\u2013376. https:\/\/doi.org\/10.1016\/j.biopsych.2017.06.004","journal-title":"Biol Psychiatry"},{"issue":"6","key":"2518_CR113","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ana.24394","volume":"77","author":"AC Kaufman","year":"2015","unstructured":"Kaufman AC, Salazar SV, Haas LT, Yang J, Kostylev MA, Jeng AT, Robinson SA, Gunther EC, van Dyck CH, Nygaard HB, Strittmatter SM (2015) Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann Neurol 77(6):953\u2013971. https:\/\/doi.org\/10.1002\/ana.24394","journal-title":"Ann Neurol"},{"key":"2518_CR114","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuropharm.2017.11.042","volume":"130","author":"LM Smith","year":"2018","unstructured":"Smith LM, Zhu R, Strittmatter SM (2018) Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer\u2019s model. Neuropharmacology 130:54\u201361. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.042","journal-title":"Neuropharmacology"},{"issue":"1","key":"2518_CR115","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-015-0119-0","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA, Kaufman AC, Rosenberg BJ, Sekine-Konno T, Varma P, Chen K, Koleske AJ, Reiman EM, Strittmatter SM, van Dyck CH (2015) A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 7(1):35. https:\/\/doi.org\/10.1186\/s13195-015-0119-0","journal-title":"Alzheimer's Res Ther"},{"key":"2518_CR116","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2050","author":"CH van Dyck","year":"2019","unstructured":"van Dyck CH, Nygaard HB, Chen K, Donohue MC, Raman R, Rissman RA, Brewer JB, Koeppe RA, Chow TW, Rafii MS, Gessert D, Choi J, Turner RS, Kaye JA, Gale SA, Reiman EM, Aisen PS, Strittmatter SM (2019) Effect of AZD0530 on cerebral metabolic decline in Alzheimer disease: a randomized clinical trial. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2050","journal-title":"JAMA Neurol"},{"issue":"9","key":"2518_CR117","doi-asserted-by":"publisher","first-page":"e7258","DOI":"10.1371\/journal.pone.0007258","volume":"4","author":"P Dubreuil","year":"2009","unstructured":"Dubreuil P, Letard S, Ciufolini M, Gros L, Humbert M, Cast\u00e9ran N, Borge L, Hajem B, Lermet A, Sippl W, Voisset E, Arock M, Auclair C, Leventhal PS, Mansfield CD, Moussy A, Hermine O (2009) Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS ONE 4(9):e7258. https:\/\/doi.org\/10.1371\/journal.pone.0007258","journal-title":"PLoS ONE"},{"issue":"1","key":"2518_CR118","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12974-016-0620-9","volume":"13","author":"E Trias","year":"2016","unstructured":"Trias E, Ibarburu S, Barreto-N\u00fa\u00f1ez R, Babdor J, Maciel TT, Guillo M, Gros L, Dubreuil P, D\u00edaz-Amarilla P, Cassina P, Mart\u00ednez-Palma L, Moura IC, Beckman JS, Hermine O, Barbeito L (2016) Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J Neuroinflammation 13(1):177. https:\/\/doi.org\/10.1186\/s12974-016-0620-9","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2518_CR119","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/alzrt75","volume":"3","author":"F Piette","year":"2011","unstructured":"Piette F, Belmin J, Vincent H, Schmidt N, Pariel S, Verny M, Marquis C, Mely J, Hugonot-Diener L, Kinet JP, Dubreuil P, Moussy A, Hermine O (2011) Masitinib as an adjunct therapy for mild-to-moderate Alzheimer\u2019s disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res Ther 3(2):16. https:\/\/doi.org\/10.1186\/alzrt75","journal-title":"Alzheimers Res Ther"},{"issue":"23","key":"2518_CR120","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1021\/jm060727j","volume":"49","author":"J Das","year":"2006","unstructured":"Das J, Chen P, Norris D, Padmanabha R, Lin J, Moquin RV, Shen Z, Cook LS, Doweyko AM, Pitt S, Pang S, Shen DR, Fang Q, de Fex HF, McIntyre KW, Shuster DJ, Gillooly KM, Behnia K, Schieven GL, Wityak J, Barrish JC (2006) 2-Aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. J Med Chem. 49(23):6819\u20136832. https:\/\/doi.org\/10.1021\/jm060727j","journal-title":"J Med Chem."},{"key":"2518_CR121","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1742-2094-9-117","volume":"9","author":"G Dhawan","year":"2012","unstructured":"Dhawan G, Combs CK (2012) Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer\u2019s disease. J Neuroinflammation 9:117. https:\/\/doi.org\/10.1186\/1742-2094-9-117","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2518_CR122","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","volume":"52","author":"MS Pollanen","year":"1993","unstructured":"Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52(3):183\u2013191","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"2518_CR123","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11910-012-0283-6","volume":"12","author":"CJ Barnum","year":"2012","unstructured":"Barnum CJ, Tansey MG (2012) Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson\u2019s disease? Curr Neurol Neurosci Rep 12(4):350\u2013358. https:\/\/doi.org\/10.1007\/s11910-012-0283-6","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2518_CR124","doi-asserted-by":"publisher","first-page":"631375","DOI":"10.3389\/fphar.2021.631375","volume":"12","author":"H Saminathan","year":"2021","unstructured":"Saminathan H, Ghosh A, Zhang D, Song C, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2021) Fyn kinase-mediated PKC\u03b4 Y311 phosphorylation induces dopaminergic degeneration in cell culture and animal models: implications for the identification of a new pharmacological target for Parkinson\u2019s disease. Front Pharmacol 12:631375. https:\/\/doi.org\/10.3389\/fphar.2021.631375","journal-title":"Front Pharmacol"},{"issue":"5","key":"2518_CR125","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuro.2011.06.009","volume":"32","author":"H Saminathan","year":"2011","unstructured":"Saminathan H, Asaithambi A, Anantharam V, Kanthasamy AG, Kanthasamy A (2011) Environmental neurotoxic pesticide dieldrin activates a non receptor tyrosine kinase to promote PKC\u03b4-mediated dopaminergic apoptosis in a dopaminergic neuronal cell model. Neurotoxicology 32(5):567\u2013577. https:\/\/doi.org\/10.1016\/j.neuro.2011.06.009","journal-title":"Neurotoxicology"},{"issue":"1","key":"2518_CR126","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1124\/mol.65.1.121","volume":"65","author":"AW Dunah","year":"2004","unstructured":"Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG (2004) Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol Pharmacol 65(1):121\u2013129. https:\/\/doi.org\/10.1124\/mol.65.1.121","journal-title":"Mol Pharmacol"},{"issue":"6","key":"2518_CR127","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.1007\/s12035-017-0748-3","volume":"55","author":"S Sanz-Blasco","year":"2018","unstructured":"Sanz-Blasco S, Bordone MP, Damianich A, Gomez G, Bernardi MA, Isaja L, Taravini IR, Hanger DP, Avale ME, Gershanik OS, Ferrario JE (2018) The kinase Fyn as a novel intermediate in L-DOPA-induced dyskinesia in Parkinson\u2019s disease. Mol Neurobiol 55(6):5125\u20135136. https:\/\/doi.org\/10.1007\/s12035-017-0748-3","journal-title":"Mol Neurobiol"},{"key":"2518_CR128","doi-asserted-by":"publisher","unstructured":"Bordone MP, Damianich A, Bernardi MA, Eidelman T, Sanz-Blasco S, Gershanik OS, Avale ME, Ferrario JE (2021) Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson's disease. eNeuro 8(4):ENEURO.0559-20. https:\/\/doi.org\/10.1523\/eneuro.0559-20.2021","DOI":"10.1523\/eneuro.0559-20.2021"},{"issue":"7","key":"2518_CR129","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo AI, Manda G, Bosc\u00e1 L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9(7):1687. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"issue":"6","key":"2518_CR130","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1084\/jem.20182191","volume":"216","author":"N Panicker","year":"2019","unstructured":"Panicker N, Sarkar S, Harischandra DS, Neal M, Kam T-I, Jin H, Saminathan H, Langley M, Charli A, Samidurai M, Rokad D, Ghaisas S, Pletnikova O, Dawson VL, Dawson TM, Anantharam V, Kanthasamy AG, Kanthasamy A (2019) Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med 216(6):1411\u20131430. https:\/\/doi.org\/10.1084\/jem.20182191","journal-title":"J Exp Med"},{"issue":"2","key":"2518_CR131","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.it.2015.12.008","volume":"37","author":"E Ellwardt","year":"2016","unstructured":"Ellwardt E, Walsh JT, Kipnis J, Zipp F (2016) Understanding the role of T cells in CNS homeostasis. Trends Immunol 37(2):154\u2013165. https:\/\/doi.org\/10.1016\/j.it.2015.12.008","journal-title":"Trends Immunol"},{"issue":"1","key":"2518_CR132","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bbrc.2017.11.143","volume":"495","author":"HM Ko","year":"2018","unstructured":"Ko HM, Lee SH, Bang M, Kim KC, Jeon SJ, Park Y-M, Han S-H, Kim HY, Lee J, Shin CY (2018) Tyrosine kinase Fyn regulates iNOS expression in LPS-stimulated astrocytes via modulation of ERK phosphorylation. Biochem Biophys Res Commun 495(1):1214\u20131220. https:\/\/doi.org\/10.1016\/j.bbrc.2017.11.143","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2518_CR133","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/1673-5374.290881","volume":"16","author":"Z-Y Yang","year":"2021","unstructured":"Yang Z-Y, Jin W-L, Xu Y, Jin M-Z (2021) Microglia in neurodegenerative diseases. Neural Regen Res 16(2):270. https:\/\/doi.org\/10.4103\/1673-5374.290881","journal-title":"Neural Regen Res"},{"issue":"5","key":"2518_CR134","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","volume":"10","author":"J Yan","year":"2014","unstructured":"Yan J, Fu Q, Cheng L, Zhai M, Wu W, Huang L, Du G (2014) Inflammatory response in Parkinson\u2019s disease (Review). Mol Med Rep 10(5):2223\u20132233. https:\/\/doi.org\/10.3892\/mmr.2014.2563","journal-title":"Mol Med Rep"},{"issue":"3","key":"2518_CR135","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/jnr.20562","volume":"81","author":"SU Kim","year":"2005","unstructured":"Kim SU, de Vellis J (2005) Microglia in health and disease. J Neurosci Res 81(3):302\u2013313. https:\/\/doi.org\/10.1002\/jnr.20562","journal-title":"J Neurosci Res"},{"issue":"8","key":"2518_CR136","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291. https:\/\/doi.org\/10.1212\/wnl.38.8.1285","journal-title":"Neurology"},{"issue":"3","key":"2518_CR137","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37(3):510\u2013518. https:\/\/doi.org\/10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"key":"2518_CR138","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2016.04.008","volume":"93","author":"R Gordon","year":"2016","unstructured":"Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, Hogan C, Sarkar S, Rokad D, Panicker N, Anantharam V, Kanthasamy AG, Kanthasamy A (2016) Protein kinase C\u03b4 upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson\u2019s disease. Neurobiol Dis 93:96\u2013114. https:\/\/doi.org\/10.1016\/j.nbd.2016.04.008","journal-title":"Neurobiol Dis"},{"key":"2518_CR139","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2017.11.008","volume":"110","author":"S Sharma","year":"2018","unstructured":"Sharma S, Carlson S, Puttachary S, Sarkar S, Showman L, Putra M, Kanthasamy AG, Thippeswamy T (2018) Role of the Fyn-PKCdelta signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy. Neurobiol Dis 110:102\u2013121. https:\/\/doi.org\/10.1016\/j.nbd.2017.11.008","journal-title":"Neurobiol Dis"},{"key":"2518_CR140","doi-asserted-by":"publisher","DOI":"10.1172\/jci136174","author":"S Sarkar","year":"2020","unstructured":"Sarkar S, Nguyen HM, Malovic E, Luo J, Langley M, Palanisamy BN, Singh N, Manne S, Neal M, Gabrielle M, Abdalla A, Anantharam P, Rokad D, Panicker N, Singh V, Ay M, Charli A, Harischandra D, Jin L-W, Jin H, Rangaraju S, Anantharam V, Wulff H, Kanthasamy AG (2020) Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson\u2019s disease. J Clin Investig. https:\/\/doi.org\/10.1172\/jci136174","journal-title":"J Clin Investig"},{"issue":"6","key":"2518_CR141","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1158\/0008-5472.CAN-07-1182","volume":"68","author":"N Dey","year":"2008","unstructured":"Dey N, Crosswell HE, De P, Parsons R, Peng Q, Su JD, Durden DL (2008) The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 68(6):1862\u20131871. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1182","journal-title":"Cancer Res"},{"issue":"9","key":"2518_CR142","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","volume":"41","author":"F Giovannoni","year":"2020","unstructured":"Giovannoni F, Quintana FJ (2020) The role of astrocytes in CNS inflammation. Trends Immunol 41(9):805\u2013819. https:\/\/doi.org\/10.1016\/j.it.2020.07.007","journal-title":"Trends Immunol"},{"key":"2518_CR143","doi-asserted-by":"publisher","unstructured":"Charron G, Doudnikoff E, Canron M-H, Li Q, Vega CL, Marais S, Baufreton JRM, Vital A, Oliet SPHR, Bezard E (2014) Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology? Front Aging Neurosci 6(1):258. https:\/\/doi.org\/10.3389\/fnagi.2014.00258","DOI":"10.3389\/fnagi.2014.00258"},{"issue":"7638","key":"2518_CR144","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung W-S, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"key":"2518_CR145","doi-asserted-by":"publisher","unstructured":"Lee C, Low CYB, Wong SY, Lai MKP, Tan MGK (2017) Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes. Sci Rep 7(1):43651. https:\/\/doi.org\/10.1038\/srep43651","DOI":"10.1038\/srep43651"},{"issue":"3","key":"2518_CR146","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","volume":"372","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee SJ (2008) Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 372(3):423\u2013428. https:\/\/doi.org\/10.1016\/j.bbrc.2008.05.045","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2518_CR147","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1471-4159.2009.06150.x","volume":"110","author":"JY Park","year":"2009","unstructured":"Park JY, Kim KS, Lee SB, Ryu JS, Chung KC, Choo YK, Jou I, Kim J, Park SM (2009) On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft. J Neurochem 110(1):400\u2013411. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06150.x","journal-title":"J Neurochem"},{"issue":"6","key":"2518_CR148","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong J-S, Zhang J (2005) Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19(6):533\u2013542. https:\/\/doi.org\/10.1096\/fj.04-2751com","journal-title":"FASEB J"},{"issue":"1\u20132","key":"2518_CR149","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0165-5728(99)00046-6","volume":"97","author":"VR Lombardi","year":"1999","unstructured":"Lombardi VR, Garcia M, Rey L, Cacabelos R (1999) Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer\u2019s Disease (AD) individuals. J Neuroimmunol 97(1\u20132):163\u2013171. https:\/\/doi.org\/10.1016\/s0165-5728(99)00046-6","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2518_CR150","doi-asserted-by":"publisher","first-page":"e00513","DOI":"10.1016\/j.heliyon.2018.e00513","volume":"4","author":"MN Olesen","year":"2018","unstructured":"Olesen MN, Christiansen JR, Petersen SV, Jensen PH, Paslawski W, Romero-Ramos M, Sanchez-Guajardo V (2018) CD4 T cells react to local increase of \u03b1-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology. Heliyon 4(1):e00513. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00513","journal-title":"Heliyon"},{"issue":"8","key":"2518_CR151","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00702-013-1149-z","volume":"121","author":"G Ambrosi","year":"2014","unstructured":"Ambrosi G, Cerri S, Blandini F (2014) A further update on the role of excitotoxicity in the pathogenesis of Parkinson\u2019s disease. J Neural Transm 121(8):849\u2013859. https:\/\/doi.org\/10.1007\/s00702-013-1149-z","journal-title":"J Neural Transm"},{"issue":"11","key":"2518_CR152","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Miranda HV, Batalha VL, Coelho JE, Szeg\u00f6 \u00c9M, Marques-Morgado I, Vaz SH, Rhee JS, Schmitz M, Zerr I, Lopes LV, Outeiro TF (2017) \u03b1-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci 20(11):1569\u20131579. https:\/\/doi.org\/10.1038\/nn.4648","journal-title":"Nat Neurosci"},{"issue":"10","key":"2518_CR153","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/emboj.2011.86","volume":"30","author":"UK Resenberger","year":"2011","unstructured":"Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Muller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, Multhaup G, Winklhofer KF, Tatzelt J (2011) The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J 30(10):2057\u20132070. https:\/\/doi.org\/10.1038\/emboj.2011.86","journal-title":"EMBO J"},{"issue":"11","key":"2518_CR154","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/mds.27478","volume":"33","author":"IC Br\u00e1s","year":"2018","unstructured":"Br\u00e1s IC, Lopes LV, Outeiro TF (2018) Sensing \u03b1-synuclein from the outside via the prion protein: implications for neurodegeneration. Mov Disord 33(11):1675\u20131684. https:\/\/doi.org\/10.1002\/mds.27478","journal-title":"Mov Disord"},{"issue":"4","key":"2518_CR155","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"W-W Chen","year":"2016","unstructured":"Chen W-W, Zhang X, Huang W-J (2016) Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 13(4):3391\u20133396. https:\/\/doi.org\/10.3892\/mmr.2016.4948","journal-title":"Mol Med Rep"},{"issue":"49","key":"2518_CR156","doi-asserted-by":"publisher","first-page":"47373","DOI":"10.1074\/jbc.M208788200","volume":"277","author":"KJ Moore","year":"2002","unstructured":"Moore KJ, El Khoury J, Medeiros LA, Terada K, Geula C, Luster AD, Freeman MW (2002) A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 277(49):47373\u201347379. https:\/\/doi.org\/10.1074\/jbc.M208788200","journal-title":"J Biol Chem"},{"issue":"37","key":"2518_CR157","doi-asserted-by":"publisher","first-page":"27392","DOI":"10.1074\/jbc.M702887200","volume":"282","author":"LM Stuart","year":"2007","unstructured":"Stuart LM, Bell SA, Stewart CR, Silver JM, Richard J, Goss JL, Tseng AA, Zhang A, El Khoury JB, Moore KJ (2007) CD36 signals to the actin cytoskeleton and regulates microglial migration via a p130Cas complex. J Biol Chem 282(37):27392\u201327401. https:\/\/doi.org\/10.1074\/jbc.M702887200","journal-title":"J Biol Chem"},{"issue":"2","key":"2518_CR158","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/bpa.12477","volume":"27","author":"W Barclay","year":"2017","unstructured":"Barclay W, Shinohara ML (2017) Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathol 27(2):213\u2013219. https:\/\/doi.org\/10.1111\/bpa.12477","journal-title":"Brain Pathol"},{"issue":"7434","key":"2518_CR159","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493(7434):674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"key":"2518_CR160","doi-asserted-by":"publisher","first-page":"105410","DOI":"10.1016\/j.nbd.2021.105410","volume":"156","author":"S Sharma","year":"2021","unstructured":"Sharma S, Carlson S, Gregory-Flores A, Hinojo-Perez A, Olson A, Thippeswamy T (2021) Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src\/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy. Neurobiol Dis 156:105410. https:\/\/doi.org\/10.1016\/j.nbd.2021.105410","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2518_CR161","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0896-6273(02)00633-5","volume":"34","author":"KA Pelkey","year":"2002","unstructured":"Pelkey KA, Askalan R, Paul S, Kalia LV, Nguyen T-H, Pitcher GM, Salter MW, Lombroso PJ (2002) Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron 34(1):127\u2013138. https:\/\/doi.org\/10.1016\/s0896-6273(02)00633-5","journal-title":"Neuron"},{"issue":"11","key":"2518_CR162","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1111\/j.1460-9568.2006.04837.x","volume":"23","author":"SP Braithwaite","year":"2006","unstructured":"Braithwaite SP, Adkisson M, Leung J, Nava A, Masterson B, Urfer R, Oksenberg D, Nikolich K (2006) Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP). Eur J Neurosci 23(11):2847\u20132856. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04837.x","journal-title":"Eur J Neurosci"},{"key":"2518_CR163","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2015.01.007","volume":"92","author":"X Zhang","year":"2015","unstructured":"Zhang X, Chergui K (2015) Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors. Neuropharmacology 92:108\u2013115. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.01.007","journal-title":"Neuropharmacology"},{"key":"2518_CR164","doi-asserted-by":"publisher","unstructured":"Venkitaramani DV, Chin J, Netzer WJ, Gouras GK, Lesne S, Malinow R, Lombroso PJ (2007) Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci 27(44):11832\u201311837. https:\/\/doi.org\/10.1523\/JNEUROSCI.3478-07.2007","DOI":"10.1523\/JNEUROSCI.3478-07.2007"},{"issue":"8","key":"2518_CR165","doi-asserted-by":"publisher","first-page":"e1001923","DOI":"10.1371\/journal.pbio.1001923","volume":"12","author":"J Xu","year":"2014","unstructured":"Xu J, Chatterjee M, Baguley TD, Brouillette J, Kurup P, Ghosh D, Kanyo J, Zhang Y, Seyb K, Ononenyi C, Foscue E, Anderson GM, Gresack J, Cuny GD, Glicksman MA, Greengard P, Lam TT, Tautz L, Nairn AC, Ellman JA, Lombroso PJ (2014) Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer\u2019s disease. PLoS Biol 12(8):e1001923. https:\/\/doi.org\/10.1371\/journal.pbio.1001923","journal-title":"PLoS Biol"},{"issue":"4","key":"2518_CR166","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1073\/pnas.1417423112","volume":"112","author":"PK Kurup","year":"2015","unstructured":"Kurup PK, Xu J, Videira RA, Ononenyi C, Baltazar G, Lombroso PJ, Nairn AC (2015) STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson\u2019s disease. Proc Natl Acad Sci 112(4):1202\u20131207. https:\/\/doi.org\/10.1073\/pnas.1417423112","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"2518_CR167","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.bbrc.2018.01.148","volume":"496","author":"X Shi","year":"2018","unstructured":"Shi X, Sun Y, Wang P, Gu L, Wang L, Yang H, Wei Q, Li Z, Luo J (2018) The interaction between calcineurin and \u03b1-synuclein is regulated by calcium and calmodulin. Biochem Biophys Res Commun 496(4):1109\u20131114. https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.148","journal-title":"Biochem Biophys Res Commun"},{"key":"2518_CR168","doi-asserted-by":"publisher","unstructured":"Liu J, Wang F (2017) Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 8(1). https:\/\/doi.org\/10.3389\/fimmu.2017.01005","DOI":"10.3389\/fimmu.2017.01005"},{"issue":"1","key":"2518_CR169","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/1673-5374.286954","volume":"16","author":"A-P Wang","year":"2021","unstructured":"Wang A-P, Tian Y, Zhang W, Tian T, Gong S-X, Huang W-Q, Zhou Q-Y (2021) Microglia-associated neuroinflammation is a potential therapeutic target for ischemic stroke. Neural Regen Res 16(1):6. https:\/\/doi.org\/10.4103\/1673-5374.286954","journal-title":"Neural Regen Res"},{"issue":"3","key":"2518_CR170","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/bc.bc_18_17","volume":"3","author":"D Lozano","year":"2017","unstructured":"Lozano D, Schimmel S, Acosta S (2017) Neuroinflammation in traumatic brain injury: a chronic response to an acute injury. Brain Circ 3(3):135. https:\/\/doi.org\/10.4103\/bc.bc_18_17","journal-title":"Brain Circ"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02518-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T15:23:11Z","timestamp":1637162591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":170,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2518"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02518-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"14 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}